Clinical Trial

Training of Relaxation Breathing in Virtual Reality Using Biofeedback: Comparison Study

Study acronym: VRrelaxBF
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated July 18, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the effectiveness of a VR-based relaxation breathing training with biofeedback compared to a non-biofeedback version in patients with anxiety disorders. The randomized controlled trial will include at least 30 participants (15 per group) diagnosed with an anxiety disorder (DSM-5 or ICD-10 criteria). The intervention will use BreezeTerraVR, a custom-built virtual reality (VR) application developed by VR research center team members at NIMH. This app provides training in deep relaxation breathing technique with or without biofeedback (BF - visual elements reflecting real-time breathing patterns measured via breathing belt) in a virtual nature environment. This study compares two subgroups of anxiety patients, both completing four 20-minute intervention sessions, two sessions with BF and two without BF (in randomized order). This study will assess the feasibility of the VR intervention, estimate effect sizes, and provide preliminary insights into its impact on relaxation training in individuals with anxiety disorders. This study is funded by the European Union's co-financed project "Research of Excellence on Digital Technologies and Wellbeing CZ.02.01.01/00/22\_008/0004583."
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-11.
Trial Details
NCT Number NCT07064629
Lead Sponsor National Institute of Mental Health, Czech Republic
Conditions Relaxation, Anxiety Disorders, Biofeedback Training
Enrollment 30 participants
Start Date 2025-01-21
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-18